Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung

Primary outcome Measures

1. evaluate the immunohistochemical expression of Glypican-1 in pleural epitheloid mesothelioma, lung adenocarcinoma and lung SCC [ Time Frame: 1 month ]
   Immunohistochemical study
2. to correlate its expression with some known clinico-pathological parameters, to evaluate its diagnostic and prognostic role. [ Time Frame: 1 month ]
   Statistical analysis

Inclusion Criteria

• Patients with pleural epithelioid mesothelioma and lung adenocarcinoma and SCC who underwent surgery

Exclusion Criteria

• Patients received pre-operative chemotherapy or radiotherapy.
• Patients with insufficient clinical data.
• Specimens with extensive necrosis
• Tiny specimens which are insufficient for accurate diagnosis.